Literature DB >> 17596310

Bovine papillomavirus E7 oncoprotein inhibits anoikis.

Joseph DeMasi1, Michael C Chao, Ashu S Kumar, Peter M Howley.   

Abstract

The bovine papillomavirus type 1 (BPV-1) E7 oncoprotein is required for the full transformation activity of the virus. Although BPV-1 E7 by itself is not sufficient to induce cellular transformation, it enhances the abilities of the other BPV-1 oncogenes to induce anchorage independence. We have been exploring the mechanisms by which E7 might affect the transformation efficiency of other viral oncoproteins and in particular whether it might protect cells from apoptosis. We report here that BPV-1 E6 and E7 can each independently inhibit anoikis, a type of apoptosis that is induced upon cell detachment. Using site-directed mutagenesis, we determined regions of the E7 protein that were essential for its antiapoptotic activity. The ability of E7 to inhibit anoikis did partially correlate with an ability to enhance anchorage independence of BPV-1 E6-transformed cells. In addition, the antiapoptotic activity of E7 also only partially correlated with its ability to bind p600, a cellular protein that has previously been reported to play a role in anoikis. We conclude that the contribution of E7 to BPV-induced cellular transformation may involve its ability to inhibit anoikis but that additional functional activities must also be involved.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17596310      PMCID: PMC1951456          DOI: 10.1128/JVI.00422-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

Review 1.  Anoikis mechanisms.

Authors:  S M Frisch; R A Screaton
Journal:  Curr Opin Cell Biol       Date:  2001-10       Impact factor: 8.382

2.  Stable association between the bovine papillomavirus E5 transforming protein and activated platelet-derived growth factor receptor in transformed mouse cells.

Authors:  L Petti; D DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

Review 3.  Integrins and anoikis.

Authors:  S M Frisch; E Ruoslahti
Journal:  Curr Opin Cell Biol       Date:  1997-10       Impact factor: 8.382

4.  Association of Bovine Papillomavirus Type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif.

Authors:  S B Vande Pol; M C Brown; C E Turner
Journal:  Oncogene       Date:  1998-01-08       Impact factor: 9.867

5.  The bovine papillomavirus E6 protein binds to the LD motif repeats of paxillin and blocks its interaction with vinculin and the focal adhesion kinase.

Authors:  X Tong; R Salgia; J L Li; J D Griffin; P M Howley
Journal:  J Biol Chem       Date:  1997-12-26       Impact factor: 5.157

6.  Cooperative transformation and coexpression of bovine papillomavirus type 1 E5 and E7 proteins.

Authors:  J Bohl; B Hull; S B Vande Pol
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

7.  The integrin-linked kinase (ILK) suppresses anoikis.

Authors:  S Attwell; C Roskelley; S Dedhar
Journal:  Oncogene       Date:  2000-08-03       Impact factor: 9.867

8.  Interaction of the bovine papillomavirus E6 protein with the clathrin adaptor complex AP-1.

Authors:  X Tong; W Boll; T Kirchhausen; P M Howley
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

9.  The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton.

Authors:  X Tong; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

10.  Disruption of epithelial cell-matrix interactions induces apoptosis.

Authors:  S M Frisch; H Francis
Journal:  J Cell Biol       Date:  1994-02       Impact factor: 10.539

View more
  17 in total

1.  Modified Anoikis Assay That Functionally Segregates Epstein-Barr Virus LMP1 Strains into Two Groups.

Authors:  Laura R Wasil; Kathy H Y Shair
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

2.  Detection and phylogenetic analysis of bovine papillomavirus in cutaneous warts in cattle in Tamaulipas, Mexico.

Authors:  Edith Rojas-Anaya; Antonio Cantú-Covarrubias; José Francisco Morales Álvarez; Elizabeth Loza-Rubio
Journal:  Can J Vet Res       Date:  2016-10       Impact factor: 1.310

Review 3.  p600/UBR4 in the central nervous system.

Authors:  Kari Parsons; Yoshihiro Nakatani; Minh Dang Nguyen
Journal:  Cell Mol Life Sci       Date:  2014-11-26       Impact factor: 9.261

Review 4.  The N-end rule pathway.

Authors:  Takafumi Tasaki; Shashikanth M Sriram; Kyong Soo Park; Yong Tae Kwon
Journal:  Annu Rev Biochem       Date:  2012-04-10       Impact factor: 23.643

5.  Papillomavirus E7 oncoproteins share functions with polyomavirus small T antigens.

Authors:  Elizabeth A White; Rebecca E Kramer; Justin H Hwang; Arun T Pores Fernando; Nana Naetar; William C Hahn; Thomas M Roberts; Brian S Schaffhausen; David M Livingston; Peter M Howley
Journal:  J Virol       Date:  2014-12-24       Impact factor: 5.103

Review 6.  Oncogenic activities of human papillomaviruses.

Authors:  Margaret E McLaughlin-Drubin; Karl Münger
Journal:  Virus Res       Date:  2009-06-18       Impact factor: 3.303

Review 7.  The human papillomavirus E7 oncoprotein.

Authors:  Margaret E McLaughlin-Drubin; Karl Münger
Journal:  Virology       Date:  2008-11-12       Impact factor: 3.616

8.  PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis.

Authors:  Joshua Hatterschide; Amelia E Bohidar; Miranda Grace; Tara J Nulton; Hee Won Kim; Brad Windle; Iain M Morgan; Karl Munger; Elizabeth A White
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-20       Impact factor: 11.205

Review 9.  The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation.

Authors:  James A Scarth; Molly R Patterson; Ethan L Morgan; Andrew Macdonald
Journal:  J Gen Virol       Date:  2021-01-11       Impact factor: 3.891

10.  Bovine papillomavirus E5 and E7 oncoproteins in naturally occurring tumors: are two better than one?

Authors:  Annunziata Corteggio; Gennaro Altamura; Franco Roperto; Giuseppe Borzacchiello
Journal:  Infect Agent Cancer       Date:  2013-01-09       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.